Biserka Relić
Impact in
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
- Cancer Research top 10%
- NF-κB Signaling Pathways
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Natural product bioactivities and synthesis 2
-
- Osteoarthritis Treatment and Mechanisms 7
- Co-authors
- Michel Malaise (19 shared papers)Marie‐Paule Merville (6 shared papers)Vincent Bours (6 shared papers)Dominique de Seny (14 shared papers)Alain Chariot (3 shared papers)Edith Charlier (8 shared papers)Sophie Neuville (11 shared papers)Mohamed Bentires‐Alj (2 shared papers)
- Journals
- Osteoarthritis and Cartilage (4 papers)PLoS ONE (2 papers)Oncogene (2 papers)Journal of Biological Chemistry (2 papers)Oncotarget (2 papers)
- Partner nations
- BelgiumSwitzerlandFrance
In The Last Decade
Biserka Relić
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Rheumatology 364
- Cancer Research 247
- Genetics 116
- Oncology 273
- Pharmacology 150
Countries citing papers authored by Biserka Relić
This map shows the geographic impact of Biserka Relić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biserka Relić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biserka Relić more than expected).
Fields of papers citing papers by Biserka Relić
This network shows the impact of papers produced by Biserka Relić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biserka Relić. The network helps show where Biserka Relić may publish in the future.
Co-authors
The 25 scholars most cited alongside Biserka Relić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 381 | |
| 2 | 2016 | 276 | |
| 3 | 2010 | 101 | |
| 4 | 2001 | 69 | |
| 5 | 2013 | 69 | |
| 6 | 2004 | 62 | |
| 7 | 1999 | 43 | |
| 8 | 2009 | 43 | |
| 9 | 2015 | 42 | |
| 10 | 2002 | 40 | |
| 11 | 2004 | 40 | |
| 12 | 2005 | 37 | |
| 13 | 2002 | 18 | |
| 14 | 2006 | 14 | |
| 15 | 2011 | 14 | |
| 16 | 2015 | 14 | |
| 17 | 2016 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2016 | 7 | |
| 20 | 2018 | 5 |
About Biserka Relić
Biserka Relić is a scholar working on Molecular Biology, Rheumatology, Epidemiology, Oncology and Pharmacology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Inflammatory mediators and NSAID effects (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), NF-κB Signaling Pathways (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Autophagy in Disease and Therapy (3 papers), Natural product bioactivities and synthesis (2 papers) and Toxoplasma gondii Research Studies (2 papers). The work is most often cited by research in Rheumatology (364 citations), Cancer Research (247 citations), Genetics (116 citations), Oncology (273 citations) and Pharmacology (150 citations). Biserka Relić has collaborated with scholars based in Belgium, Switzerland and France. Frequent co-authors include Michel Malaise, Marie‐Paule Merville, Vincent Bours, Dominique de Seny, Alain Chariot, Edith Charlier, Sophie Neuville, Mohamed Bentires‐Alj, Olivier Malaise and Véronique Barbu. Their work appears in journals such as Osteoarthritis and Cartilage, PLoS ONE, Oncogene, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.